Please login first
Chemical Composition and Biological Activity of Diterpenoids from Plectranthus mutabilis
* 1, 2 , 3 , 4 , 1, 5 , 6 , 2 , 3 , 5 , 7 , 4, 5
1  CBIOS – Center for Research in Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal
2  Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá, Ctra. A2, Km 33.600 – Campus Universitario, 28871 Alcalá de Henares, Spain
3  Institute of Pharmacognosy, University of Szeged, Eötvös str. 6. 6720 Szeged, Hungary
4  CBIOS – Center Research for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal
5  Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto 1649-003 Lisbon, Portugal
6  LAQV - Laboratório Associado para a Química Verde, Faculty of Pharmacy of University of Porto, Portugal
7  Institute for Biological Research ‘Siniˇsa Stankovi´ c’, University of Belgrade, Despota Stefana 142, 11060 Belgrade, Serbia

Abstract:

Despite the great development in human medicine, cancer is still a serious threat to public health and consequently, research on new anticancer agents should be continued. Natural products from medicinal plants (e.g., Plectranthus species) continue to be a substantial resource to treat different diseases, particularly in developing countries. Plectranthus species are rich in diterpenoids, which are reported to be responsible for various pharmacological activities such as cytotoxic activity. P. mutabilis Codd. is a perennial succulent herb containing Nepetoidins A and Nepetoidins B in its essential oils and have limited information available in the literature.

In this study, we performed an ultrasound-assisted acetone extraction of air-dried P. mutabilis whole plant followed by a bio-guided fractionation using the Artemia salina general toxicity assay that resulted in the identification of four compounds: Coleon U quinone (1), 8α,9α-Epoxycoleon U quinone (2), Coleon U (3, maor) and 7-hydro,14-deoxycoleon U (4). The cytotoxicity of the isolated compounds and P. mutabilis extract was evaluated using a model system of sensitive (NCI-H460) and MDR (NCI-H460/R) cells, along with normal human embryonal bronchial epithelial cells (MRC-5). Studies of modulation of P-gp activity are ongoing to unveil the interaction of these compounds and extract with P-gp.

Keywords: cancer, cytotoxicity, p-glycoprotein, Plectranthus mutabilis
Comments on this paper
Amina Yusuf
Question/Suggestions
Going by the title Chemical Composition and Biological Activity of Diterpenoids from Plectranthus mutabilis I would like to ask some questions such as

1. Where the researchers only interested in identification of diterpenes?

2. What informed the choice of the topic?

I think more polar constituents from the plant such as flavonoids would have exhibited more effect compared to diterpenes. Expanding the scope could have helped.

Thank you
Epole Ngolle Ntungwe
Hello Amina Yusuf, Thank you for your questions and comment.
We study Plectranthus species because they are used traditionally for the treatment of different ailment including cancer. Cytotoxicity screenings have identified Plectranthus plants as potential sources of antitumor lead compounds. Specifically, they are known to contain diterpenoids with abietane skeleton known for their cytotoxic activity. Hence the isolation of diterpenes from Pleactranthus mutabilis is therefore in agreement with other studies identifying Plectranthus species as a source of abietane diterpenoids.
Thank you



 
 
Top